
Shobha Kantamneni
Examiner (ID: 1732, Phone: (571)272-2930 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617, 1623 |
| Total Applications | 1212 |
| Issued Applications | 306 |
| Pending Applications | 120 |
| Abandoned Applications | 793 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5656610
[patent_doc_number] => 20060142346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'S-lansoprazole compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 11/359698
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3538
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359698
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359698 | S-lansoprazole compositions and methods | Feb 21, 2006 | Abandoned |
Array
(
[id] => 5068889
[patent_doc_number] => 20070189990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Ultraviolet absorber for cosmetics and polymeric materials'
[patent_app_type] => utility
[patent_app_number] => 11/355936
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2560
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20070189990.pdf
[firstpage_image] =>[orig_patent_app_number] => 11355936
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/355936 | Ultraviolet absorber for cosmetics and polymeric materials | Feb 15, 2006 | Abandoned |
Array
(
[id] => 5673009
[patent_doc_number] => 20060178364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Use of EGFR tyrosinkinase inhibitors for treatment of chronic rhinosinusitis'
[patent_app_type] => utility
[patent_app_number] => 11/275903
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5009
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178364.pdf
[firstpage_image] =>[orig_patent_app_number] => 11275903
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/275903 | Use of EGFR tyrosinkinase inhibitors for treatment of chronic rhinosinusitis | Feb 1, 2006 | Abandoned |
Array
(
[id] => 5189209
[patent_doc_number] => 20070167518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Anti-tussive and bronchodilator actions of Enaminone E121'
[patent_app_type] => utility
[patent_app_number] => 11/307003
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1410
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167518.pdf
[firstpage_image] =>[orig_patent_app_number] => 11307003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/307003 | Anti-tussive and bronchodilator actions of Enaminone E121 | Jan 17, 2006 | Abandoned |
Array
(
[id] => 5760739
[patent_doc_number] => 20060211684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Use of alpha-2 adrenergic receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/331591
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8901
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11331591
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/331591 | Use of alpha-2 adrenergic receptor agonists | Jan 12, 2006 | Abandoned |
Array
(
[id] => 5875273
[patent_doc_number] => 20060166969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'AMPA antagonists for the treatment of dizziness, including vertigo and Meniere\'s disorder'
[patent_app_type] => utility
[patent_app_number] => 11/331026
[patent_app_country] => US
[patent_app_date] => 2006-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2334
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166969.pdf
[firstpage_image] =>[orig_patent_app_number] => 11331026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/331026 | AMPA antagonists for the treatment of dizziness, including vertigo and Meniere's disorder | Jan 12, 2006 | Abandoned |
Array
(
[id] => 6084156
[patent_doc_number] => 20110144128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands'
[patent_app_type] => utility
[patent_app_number] => 11/813482
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64967
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144128.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813482
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813482 | Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands | Jan 5, 2006 | Abandoned |
Array
(
[id] => 5632401
[patent_doc_number] => 20060148871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Metabolic stabilization of substituted adamantane'
[patent_app_type] => utility
[patent_app_number] => 11/325956
[patent_app_country] => US
[patent_app_date] => 2006-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4543
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148871.pdf
[firstpage_image] =>[orig_patent_app_number] => 11325956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/325956 | Metabolic stabilization of substituted adamantane | Jan 4, 2006 | Abandoned |
Array
(
[id] => 5649877
[patent_doc_number] => 20060135612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent'
[patent_app_type] => utility
[patent_app_number] => 11/304612
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8194
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135612.pdf
[firstpage_image] =>[orig_patent_app_number] => 11304612
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/304612 | Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), by using a HDAC inhibiting agent | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5808253
[patent_doc_number] => 20060094608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Warming and nonirritating lubricant compositions and method of comparing irritation'
[patent_app_type] => utility
[patent_app_number] => 11/299884
[patent_app_country] => US
[patent_app_date] => 2005-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5088
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094608.pdf
[firstpage_image] =>[orig_patent_app_number] => 11299884
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/299884 | Warming and nonirritating lubricant compositions and method of comparing irritation | Dec 11, 2005 | Abandoned |
Array
(
[id] => 5813216
[patent_doc_number] => 20060083774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Neurophilin ligands for treating ocular conditions'
[patent_app_type] => utility
[patent_app_number] => 11/295033
[patent_app_country] => US
[patent_app_date] => 2005-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1875
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11295033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/295033 | Neurophilin ligands for treating ocular conditions | Dec 5, 2005 | Abandoned |
Array
(
[id] => 5331309
[patent_doc_number] => 20090111786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Compounds that Prevent Macrophage Apoptosis and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/792154
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 23114
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111786.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792154 | Compounds that Prevent Macrophage Apoptosis and Uses Thereof | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5705767
[patent_doc_number] => 20060194815
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Methods and compositions for modulating serum cortisol levels'
[patent_app_type] => utility
[patent_app_number] => 11/293866
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18445
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194815.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293866
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293866 | Methods and compositions for modulating serum cortisol levels | Dec 1, 2005 | Abandoned |
Array
(
[id] => 5875579
[patent_doc_number] => 20060167114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors'
[patent_app_type] => utility
[patent_app_number] => 11/291509
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7570
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167114.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291509
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291509 | Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5829004
[patent_doc_number] => 20060063740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'Method for inhibiting bone resorption'
[patent_app_type] => utility
[patent_app_number] => 11/273470
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9706
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063740.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273470
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273470 | Method for inhibiting bone resorption | Nov 13, 2005 | Abandoned |
Array
(
[id] => 5880545
[patent_doc_number] => 20060029627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-09
[patent_title] => 'Antipruritic composition and wound-healing-promoting composition'
[patent_app_type] => utility
[patent_app_number] => 11/249387
[patent_app_country] => US
[patent_app_date] => 2005-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20060029627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249387 | Antipruritic composition and wound-healing-promoting composition | Oct 13, 2005 | Abandoned |
Array
(
[id] => 5211093
[patent_doc_number] => 20070249677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Treatment of Osteoarthritis and Dosing Regimen for Arzoxifene'
[patent_app_type] => utility
[patent_app_number] => 11/575429
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7486
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249677.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575429
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575429 | Treatment of Osteoarthritis and Dosing Regimen for Arzoxifene | Oct 12, 2005 | Abandoned |
Array
(
[id] => 5710044
[patent_doc_number] => 20060051389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Sustained release polymer-based water insoluble beads'
[patent_app_type] => utility
[patent_app_number] => 11/250027
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5675
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11250027
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/250027 | Sustained release polymer-based water insoluble beads | Oct 12, 2005 | Abandoned |
Array
(
[id] => 5721281
[patent_doc_number] => 20060074057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Use of chenodeoxycholic acid for reducing adipose tissue'
[patent_app_type] => utility
[patent_app_number] => 11/242747
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1369
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20060074057.pdf
[firstpage_image] =>[orig_patent_app_number] => 11242747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/242747 | Use of chenodeoxycholic acid for reducing adipose tissue | Oct 3, 2005 | Abandoned |
Array
(
[id] => 5576053
[patent_doc_number] => 20090143415
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain'
[patent_app_type] => utility
[patent_app_number] => 11/663268
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4966
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20090143415.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663268
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663268 | Tetrodotoxin And Its Derivatives For The Treatment Of Central-Nervously Derived Neuropathic Pain | Sep 20, 2005 | Abandoned |